Use of integrative and complementary practices in patients with COVID-19: A scoping review
DOI:
https://doi.org/10.33448/rsd-v10i5.14160Keywords:
Complementary Therapies; Complementary and Alternative Medicine; COVID-19; SARS-CoV-2.Abstract
Objective: to map in the literature the recommendations and considerations on the use of integrative and complementary practices in patients with COVID-19, identifying the perspectives and gaps that exist in this production. Method: a scoping review, carried out in the following databases: National Library of Medicine via PubMed®, Current Nursing and Allied Health Literature, Scopus, Embase, Web of Science, Latin American and Caribbean Literature on Health Sciences via the National Health Library, Americas Traditional Complementary and Integrative Medicine and in the National Observatory of Traditional, Integrative and Complementary Knowledge and Practices, including 20 studies with different methodological approaches that answered the following question: “What are the recommendations or considerations on the use of integrative and complementary practices in patients with COVID-19?” Results: the studies were originated mainly in China, presented varied methodological designs, and addressed 13 of the 29 practices included in the National Policy of Integrative and Complementary Practices. Among these, Traditional Chinese Medicine, with discussions involving phytotherapy, stood out. In general, the practices acted mainly in reducing the symptoms caused by COVID-19 and can contribute to the treatment of the disease. Conclusion: although there is an urgent need for more studies that investigate the use of integrative and complementary practices in patients with COVID-19, these therapies can assist in the treatment, in the prevention of diseases, and in the recovery of the patients.
References
Ang, L., Song, E., Lee, H. W., & Lee, M. S. (2020). Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine, 9(5), 1583. https://doi.org/10.3390/jcm9051583.
Asociación China de Acupuntura-Moxibustión. (2020). Guía sobre el uso de acupuntura y moxibustión para tratar COVID-19 (segunda edición). Revista Internacional de Acupuntura, 14(1),13-16. https://doi.org/10.1016/j.acu.2020.04.001.
Biblioteca Virtual em Saúde. (2020). Medicinas Tradicionais Complementares e Integrativas (MTCI). Mapa de evidências: Contribuições das MTCI para COVID-19. https://mtci.bvsalud.org/pt/contribuicoes-das-medicinas-tradicionais-complementares-e-integrativas-mtci-no-contexto-do-covid-19/.
Brasil. (2020). Ministério da Saúde. Conselho Nacional de Saúde. Nota explicativa: CNS nunca recomendou práticas integrativas em saúde como tratamento medicamentoso de Covid-19. http://conselho.saude.gov.br/ultimas-noticias-cns/1202-nota-explicativa-cns-nunca-recomendou-praticas-integrativas-em-saude-como-tratamento-medicamentoso-de-covid-.
Brasil. (2020). Ministério da Saúde. Conselho Nacional de Saúde. Recomendação nº 041 de 21 de maio de 2020. Recomenda ações sobre o uso das práticas integrativas e complementares durante a pandemia. http://conselho.saude.gov.br/recomendacoes-cns/1192-recomendacao-n-041-de-21-de-maio-de-2020.
Brasil. (2006). Ministério da Saúde. Política Nacional de Práticas Integrativas e Complementares no SUS. https://bvsms.saude.gov.br/bvs/publicacoes/pnpic.pdf.
Brasil. (2017). Ministério da Saúde. Portaria GM/MS nº 849 de 27 de março de 2017. Inclui a Arteterapia, Ayurveda, Biodança, Dança Circular, Meditação, Musicoterapia, Naturopatia, Osteopatia, Quiropraxia, Reflexoterapia, Reiki, Shantala, Terapia Comunitária Integrativa e Yoga à Política Nacional de Práticas Integrativas e Complementares. Diário Oficial da União 2017, 27 de março. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt0849_28_03_2017.html.
Brasil. (2018). Ministério da Saúde. Portaria GM/MS nº 702 de 21 de março de 2018. Altera a Portaria de Consolidação nº 2/GM/MS, de 28 de setembro de 2017, para incluir novas práticas na Política Nacional de Práticas Integrativas e Complementares – PNPIC [Internet]. Diário Oficial da União 2018, 21 de março. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2018/prt0702_22_03_2018.html#:~:text=Altera%20a%20Portaria%20de%20Consolida%C3%A7%C3%A3o,Pr%C3%A1ticas%20Integrativas%20e%20Complementares%20%2D%20PNPIC.&text=1%C2%BA%20Ficam%20inclu%C3%ADdas%20novas%20pr%C3%A1ticas,Pr%C3%A1ticas%20Integrativas%20e%20Complementares%20%2D%20PNPIC.
Chan, K. W., Wong, V. T., & Tang, S. C. W. (2020). COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese – Western Medicine for the Management of 2019 Novel Coronavirus Disease. The American Journal of Chinese Medicine, 48(3), 737–762. https://doi.org/10.1142/S0192415X20500378.
Ch’ng, E. S., & Tang, T. H. (2020). Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections?. Malaysian Journal of Medical Sciences, 27(3), 150–152. https://doi.org/10.21315/mjms2020.27.3.16.
Fan, A. Y., Gu, S., & Alemi, S. F. (2020). Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine,18(5):385–394. https://doi.org/10.1016/j.joim.2020.07.008.
Feng, F., Tuchman, S., Denninger, J. W., Fricchione, G. L., & Yeung, A. (2020). Qigong for the Prevention, Treatment, and Rehabilitation of COVID-19 Infection in Older Adults. The American Journal of Geriatric Psychiatry, 28(8), 812–819. https://doi.org/10.1016/j.jagp.2020.05.012.
Ganguly, S., & Bakhshi, S. (2020). Traditional and complementary medicine during Covid-19 pandemic. Phytotherapy Research, 34, 3083-3084. https://doi.org/10.1002/ptr.6828.
Gray, P. E., & Belessis, Y. (2020). The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good. Pharmacological Research, 156, 104776. https://doi.org/10.1016/j.phrs.2020.104776.
Liu, M., Gao, Y., Yuan, Y., Yang, K., Shi, S., Zhang, J., & Tian, J. (2020). Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta- analysis. Pharmacological Research,158, 104896. https://doi.org/10.1016/j.phrs.2020.104896.
Luo, H., Tang, Q., Shang, Y., Liang, S., Yang, M., Robinson, N., & Liu, J. (2020). Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chinese Journal Integrative Medicine, 26,243-250. https://doi.org/10.1007/s11655-020-3192-6.
Mustafa, M. Z., Shamsuddin, S. H., Sulaiman, S. A., & Abudullah, J. M. (2020). Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections. Malaysian Journal of Medical Sciences, 27(2), 165–169. https://doi.org/10.21315/mjms2020.27.2.17.
Nascimento, A. (2020). Aromaterapia: o poder das plantas e dos óleos essenciais. Recife: Fiocruz-PE. ObservaPICS. http://observapics.fiocruz.br/wp-content/uploads/2020/06/Cuidado-integral-na-Covid-Aromaterapia-ObservaPICS.pdf.
National Center for Complementary and Integrative Health. (2020). In the News: Coronavirus and “Alternative” Treatments. https://www.nccih.nih.gov/health/in-the-news-coronavirus-and-alternative-treatments.
Observatório Nacional de Saberes e Práticas Tradicionais, Integrativas e Complementares. (2020). Especial COVID-19 & PICS. http://observapics.fiocruz.br/covid-19/.
Organización Mundial de la Salud. (2013). Estrategia de la OMS sobre medicina tradicional 2014-2023. http://www.abiomac.org.br/wp-content/uploads/2014/03/Estrategia-OMS-Medicina-Tradicional-2014-2023.pdf.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan — a web and mobile app for systematic reviews. Systematic Reviews, 5, 210. https://doi.org/10.1186/s13643-016-0384-4.
Peters, M. D. J., Godfrey, C., McInerney, P., Munn, Z., Tricco, A. C., & Khalil, H. (2020). Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis, JBI. https://synthesismanual.jbi.global. doi: https://doi.org/10.46658/JBIMES-20-12.
Prado, M. F. D., Antunes, B. B. P., Bastos, L. D. S. L., Peres, I. T., Silva, A. A. B. D., Dantas, L. F.,...Bozza, F. A. (2020). Analysis of COVID-19 under-reporting in Brazil. Revista Brasileira de Terapia Intensiva, 32(2), 224-228. https://doi.org/10.5935/0103-507x.20200030.
Ren, J-L., Zhang, A-H., & Wang, X-J. (2020). Traditional Chinese medicine for COVID-19 treatment. Pharmacological Research, 155, 104743. https://doi.org/10.1016/j.phrs.2020.104743.
Secretaria do Estado de Santa Catarina. (2020). Secretaria de Estado da Saúde. Superintendência de Planejamento em Saúde. Diretoria de Atenção Primária à Saúde. Nota técnica 10/2020. Orientação para profissionais de saúde no uso de práticas integrativas e complementares no período de pandemia do COVID-19 – versão 1. Santa Catarina; 2020. https://www.saude.sc.gov.br/coronavirus/arquivos/Nota%20Tecnica_10_DAPS_SPS_SES_PICS.pdf.
Tillu, G., Chaturvedi, S., Chopra, A., & Patwardhan, B. (2020). Public Health Approach of Ayurveda and Yoga for COVID-19 Prophylaxis. The Journal of Alternative and Complementary Medicine, 26(5), 360–364. https://doi.org/10.1089/acm.2020.0129.
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D.,...Weeks, L. (2018). PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation. Annals of Internal Medicine, 169, 467–473. 10.7326/M18-0850.
Wang, S., Wang, Y., Lu, Y., Li, J., Song, Y., Nyamgerelt, M., & Wang, X. (2020). Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. Journal of Integrative Medicine, 18(4), 275–283. https://doi.org/10.1016/j.joim.2020.04.001.
World Health Organization. (2021). WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/.
Xiao, M., Tian, J., Zhou, Y., Xu, X., Min, X., Lv, Y.,...Tong, X. (2020). Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial. Pharmacological Research,161, 105126. https://doi.org/10.1016/j.phrs.2020.105126.
Xu, J., & Zhang, Y. (2020). Traditional Chinese Medicine treatment of COVID-19. Complementary Therapies in Clinical Practice, 39, 101165. https://doi.org/10.1016/j.ctcp.2020.101165.
Xu, J., Pan, L., & Jia, C. (2020). Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism. World Journal of Acupuncture – Moxibustion, 30(2), 81–84. https://doi.org/10.1016/j.wjam.2020.06.001.
Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese Medicine in the treatment of patients infected with 2019-new coronavirus (sars-cov-2): a review and perspective. International Journal of Biological Sciences, 16(10), 1708-1717. 10.7150/ijbs.45538.
Zhang, A-H., Ren, J-L., & Wang, X-J. (2020). Reply to “The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good.” Pharmacological Research, 157, 104775. https://doi.org/10.1016/j.phrs.2020.104775.
Zhang, H-T, Huang, M-X., Liu, X., Zheng, X-C., Li, X-H., Chen, G-Q.,...Hong Z-S. (2020). Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19 : A Retrospective Matched Case-Control Study. The American Journal of Chinese Medicine, 48(4),779–792. 10.1142/S0192415X20500391.
Zengli, L., Xiuhui, L., Chunyan, G., Li, L., Xiaolan, L., Chun, Z.,... Xiaojun, W. (2020). Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients. Journal of Traditional Chinese Medicine, 40(3), 467–472. 10.19852/j.cnki.jtcm.2020.03.016.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ludmila de Oliveira Ruela; Caroline de Castro Moura ; Beatriz Boleta Fernandes; Mariana Vitor Peppe; Juliana Stefanello
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
